During the third quarter of 2025, the institutional shares of the Macquarie Small Cap Value Fund recorded a return that trailed its primary benchmark, the Russell 2000 Value Index, which achieved a more robust performance.
A significant factor contributing to this disparity was the fund's stock selection choices and its reduced exposure within the healthcare industry. Furthermore, the fund's investments in the technology sector, particularly in companies involved in semiconductors and semiconductor equipment manufacturing, delivered results below expectations, adversely impacting overall fund performance.
Despite this period of underperformance, the core philosophy of strategic investment remains crucial. Market fluctuations are an inherent aspect of the investment landscape, and maintaining a disciplined approach, rooted in thorough research and a long-term perspective, can help navigate these challenges. Opportunities often emerge during such times for discerning investors to position themselves for future growth and resilience, reinforcing the importance of informed decision-making and steadfastness in the pursuit of financial objectives.
